Table 2 Baseline characteristics and comorbidity of patients with coronavirus disease (SARS-COV-2).
Mean | Std | Min–max | ||
|---|---|---|---|---|
Age of SARS-COV-2 survivors | General N = 1201 | 49.53 | 24.90 | 0–101 |
Women N = 662 | 49.98 | 25.53 | 0–101 | |
Men N = 539 | 48.97 | 24.12 | 0–101 | |
Age of non SARS-COV-2 survivors | General N = 154 | 80.89 | 13.11 | 11–101 |
Women N = 75 | 83.43 | 14.46 | 11–101 | |
Men N = 79 | 78.49 | 11.27 | 49–101 | |
Number of comorbidities in general population | General N = 10,677 | 8.89 | 9.83 | 0–77 |
Women N = 5112 | 8.40 | 9.05 | 0–77 | |
Men N = 5565 | 13.42 | 13.57 | 0–66 | |
Number of comorbidities in the deceased population | General N = 3007 | 19.52 | 11.58 | 0–63 |
Women N = 1241 | 16.77 | 9.03 | 1–54 | |
Men N = 1766 | 22.35 | 4 | 4–63 |
